These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 793885)

  • 1. [Therapeutic trial with plasmaclar in arteriosclerotic patients and modification of their cholesterol rates].
    Casado Salvador F
    Folia Clin Int (Barc); 1976 Sep; 26(9):415-9. PubMed ID: 793885
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypolipidaemic effect of xantinol nicotinate: a clinical trial.
    Dhorranintra B; Khunawat P; Patalung BN; Prabhan C
    J Med Assoc Thai; 1983 May; 66(5):269-73. PubMed ID: 6348198
    [No Abstract]   [Full Text] [Related]  

  • 3. [Lipid-lowering effect of etofibrate, bezafibrate and xanthinol nicotinate in patients with hyperlipoproteinemias].
    Machalke K; Djaja S; Richter E
    Ther Ggw; 1982 May; 121(5):301-11. PubMed ID: 6953613
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical valuation of "Plasmaclar", a new drug for the treatment of hyperlipaemias (author's transl)].
    Ferrer García JL
    Folia Clin Int (Barc); 1973 Nov; 23(11):782-94. PubMed ID: 4773216
    [No Abstract]   [Full Text] [Related]  

  • 5. [Verification of the lipid hypothesis by drug intervention].
    Levy RI
    Ter Arkh; 1985; 57(11):33-5. PubMed ID: 3909475
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapeutic effect of complamine in atherosclerosis and ischemic heart disease].
    Kalmykova VI; Aronchuk EK
    Sov Med; 1976 Jan; (1):113-8. PubMed ID: 1273633
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical trial of tibric acid, a new hypolipidemic agent].
    Noseda G; Sirtori CR
    Schweiz Med Wochenschr; 1974 Dec; 104(51):1917-22. PubMed ID: 4438990
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of clofibrate and pyridinol carbamate singly or in combination in the antiarteriosclerotic therapy].
    Meciani L; Boeri S; Ricci G
    Minerva Cardioangiol; 1974; 22(7-8):512-42. PubMed ID: 4606052
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hypolipemic therapy of occlusive arteriosclerosis of the lower extremities. Short-term biochemical results].
    Lasso M; García Merlo G; Medarde A
    Angiologia; 1973; 25(1):43-8. PubMed ID: 4685110
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of Xavin infusions in obliterating peripheral arterial disorders.
    Keller L; Landi A; Bársony J
    Ther Hung; 1975; 23(2):54-9. PubMed ID: 1188703
    [No Abstract]   [Full Text] [Related]  

  • 11. Preliminary results of sulodexide treatment in patients with peripheral arteriosclerosis and hyperlipidemia. A multicentre trial.
    Crepaldi G; Fellin R; Calabrò A; Baiocchi MR; Rossi A; Lenzi S; Descovich GC; Delmonte G; Gaddi A; Ventura A
    Monogr Atheroscler; 1986; 14():215-21. PubMed ID: 3526129
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hydroxyproline indicators before and after treatment of diabetic angiopathies].
    Spesivtseva VG; Mamaeva GG; Starosel'tseva LK; Tulemisov EU; Bokaneva IA
    Ter Arkh; 1978; 50(1):93-7. PubMed ID: 635809
    [No Abstract]   [Full Text] [Related]  

  • 13. [Current trends in the therapy of arteriosclerotic disease].
    Toscano S
    G Clin Med; 1974 Jan; 55(1):27-39. PubMed ID: 4369524
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapeutic effect of pyridylcarbinolic ester of clofibric acid on the changes of the lipid and fibrinolytic picture in arteriosclerotic patients].
    Rugginenti
    Minerva Med; 1974 May; 65(35):1906-16. PubMed ID: 4601840
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacological properties and clinical use of xanthinol nicotinate].
    Mashkovskiĭ MD; Iuzhakov SD; Absava GI; Erokhina LG; Lebedeva NV
    Klin Med (Mosk); 1984 Nov; 62(11):30-4. PubMed ID: 6097742
    [No Abstract]   [Full Text] [Related]  

  • 16. [Phosphatidylcholine in the control of arteriosclerosis].
    Salvioli G; Lugli R; Pradelli JM
    Clin Ter; 1984 Oct; 111(1):27-44. PubMed ID: 6238778
    [No Abstract]   [Full Text] [Related]  

  • 17. [Modern treatment methods in atherosclerosis].
    Aronov DM
    Ter Arkh; 1997; 69(11):75-81. PubMed ID: 9483757
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prolonged clinical study of the LA, 313-B-xanthinol niacinate pentosan sulfonate ester combination in various forms of hypertension].
    Masso M; Gimeno Martínez J; Honorato J
    Rev Clin Esp; 1976 Jul; 142(2):157-61. PubMed ID: 968103
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical trial of xanthinol nicotinate in delayed form in the treatment of arteritis of the lower limbs].
    Niquet G; Dupont T
    Lille Med; 1976 Jan; 21(1 suppl 1):13-5. PubMed ID: 1256225
    [No Abstract]   [Full Text] [Related]  

  • 20. [Sulodexide treatment approach in patients with atherosclerotic vascular disease with various localizations].
    Capone-Braga M; Tellini L; Boncompagni L; Bettoni M; Burali A; Bensi A
    Clin Ter; 1987 Jan; 120(1):25-31. PubMed ID: 2973852
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.